Approaches to tenofovir and abacavir drug shortages in South Africa: A guide for clinicians by Laurie Schowalter, Francesca Conradie

“…Shortages of the nucleoside reverse transcriptase inhibitors (NRTI) abacavir and tenofovir have been reported recently at health facilities across South Africa. …”
Get full text

Tenofovir alafenamide in the treatment of chronic hepatitis B: design, development, and place in therapy by Ogawa E, Furusyo N, Nguyen MH

Subjects: Get full text

Real World Data on Forgiveness to Uncomplete Adherence to Bictegravir/ Emtricitabine/Tenofovir Alafenamide by Franco Maggiolo, Daniela Valenti, Rodolfo Teocchi, Laura Comi, Elisa Di Filippo, Marco Rizzi

“…We explored forgiveness of bictegravir/emtricitabine/tenofovir alafenamide. Methods: drug refills were used to calculate the percent day covered (PDC) as a proxy of adherence. …”
Get full text

Emtricitabine/rilpivirine/tenofovir disoproxil fumarate for the treatment of HIV-1 infection in adults by Wissam K. Kabbara, Wijdan H. Ramadan

“…Summary: This paper reviews the current literature and information on the combination drug Complera™ (rilpivirine/emtricitabine/tenofovir disoproxil fumarate) that was approved by the Food and Drug Administration (FDA) in August 2011.PubMed, Cochrane and Embase (2001–2014) were searched for primary and review articles on rilpivirine, emtricitabine, and tenofovir disoproxil fumarate, individually or in combination. …”
Get full text

A Case of Tenofovir-associated Fanconi Syndrome in Patient with Chronic Hepatitis B by Dongwoo Kim, Jongjin Lee, Dae-ha Kim, Kyuho Kang, Sang Jun Suh, Young Kul Jung, Hyung Joon Yim

Subjects: “…Tenofovir…”
Get full text

Whole body bone scintigraphy in tenofovir-related osteomalacia: a case report by Di Biagio Antonio, Rosso Raffaella, Monteforte Patrizia, Russo Rodolfo, Rovetta Guido, Viscoli Claudio

“…<p>Abstract</p> <p>Introduction</p> <p>Tenofovir disoproxil fumarate (Viread^®) is the only nucleotide reverse transcriptase inhibitor currently approved for the treatment of HIV. …”
Get full text

Association of Tenofovir Use With Risk of Incident Heart Failure in HIV‐Infected Patients by Ruijun Chen, Rebecca Scherzer, Priscilla Y. Hsue, Vasantha Jotwani, Michelle M. Estrella, Michael A. Horberg, Carl Grunfeld, Michael G. Shlipak

Subjects: Get full text

Tenofovir-induced renal and bone toxicity: report of two cases and literature review by Carlos Eduardo Andrade Fioroti, Jesiree Iglésias Quadros Distenhreft, Bruna Bastos Paulino, Kamilla Lacchine, Danilo Rodrigues Ramos, Antonio Carlos Seguro, Weverton Machado Luchi

Subjects: “…Tenofovir Disoproxil Fumarate…”
Get full text

Prevention of rectal SHIV transmission in macaques by daily or intermittent prophylaxis with emtricitabine and tenofovir. by J Gerardo García-Lerma, Ron A Otten, Shoukat H Qari, Eddie Jackson, Mian-Er Cong, Silvina Masciotra, Wei Luo, Caryn Kim, Debra R Adams, Michael Monsour, Jonathan Lipscomb, Jeffrey A Johnson, David Delinsky, Raymond F Schinazi, Robert Janssen, Thomas M Folks, Walid Heneine

“…Group 1 was treated subcutaneously with a human-equivalent dose of emtricitabine (FTC), group 2 received orally the human-equivalent dosing of both FTC and tenofovir-disoproxil fumarate (TDF), and group 3 received subcutaneously a similar dosing of FTC and a higher dose of tenofovir. …”
Get full text

Body weight changes in treated hepatitis B patients switching to tenofovir alafenamide☆ by Ming-Lun Yeh, Po-Cheng Liang, Sam Trinh, Ching-I Huang, Chung-Feng Huang, Ming-Yen Hsieh, Jee-Fu Huang, Chia-Yen Dai, Wan-Long Chuang, Mindie H. Nguyen, Ming-Lung Yu

Subjects: “…Tenofovir alafenamide…”
Get full text

Is the tenofovir based therapy almighty for previous treatment failure in chronic hepatitis B? by Hyung Joon Yim

Subjects: Get full text

Synthesis and characterization of a conjugate of silver nanoparticles loaded with tenofovir disoproxil fumarate by Samuel Oluwaseun Olojede, Sodiq Kolawole Lawal, Nomfundo Mahlangeni, Bongisiwe Shelembe, Matome Nadab Matshipi, Roshila Moodley, Carmen Olivia Rennie, Edwin Coleridge Naidu, Onyemaechi Okpara Azu

Subjects: Get full text

Linking the Population Pharmacokinetics of Tenofovir and Its Metabolites With Its Cellular Uptake and Metabolism by K Madrasi, R N Burns, C W Hendrix, M J Fossler, A Chaturvedula

“…Empirical pharmacokinetic models are used to explain the pharmacokinetics of the antiviral drug tenofovir (TFV) and its metabolite TFV diphosphate (TFV‐DP) in peripheral blood mononuclear cells. …”
Get full text

Clinical Images: Tenofovir‐Induced Fanconi Syndrome: An Uncommon Cause of Hypophosphatemic Osteomalacia by Rasmi Ranjan Sahoo, Anupam Wakhlu

Get full text

Early Onset of Tenofovir-Induced Renal Failure: Case Report and Review of the Literature by Shilpa M. Patel, Teresa R. Zembower, Frank Palella, Yashpal S. Kanwar, Shubhada N. Ahya

“…Tenofovir is an acyclic nucleotide analogue reverse transcriptase inhibitor that is commonly prescribed as part of a highly active antiretroviral therapy (HAART) regimen in HIV-infected patients. …”
Get full text

Simple Spectrophotometric Methods for Determination of Tenofovir Fumarate and Emtricitabine in Bulk Powder and in Tablets by Mohammad H. AbdelHay, Azza A. Gazy, Rasha A. Shaalan, Heba K. Ashour

“…Two simple and selective methods were developed for the simultaneous determination of tenofovir fumarate (TEN) and emtricitabine (EMT) in combined tablets. …”
Get full text

In vitro and ex vivo testing of tenofovir shows it is effective as an HIV-1 microbicide. by Lisa C Rohan, Bernard J Moncla, Ratiya Pamela Kunjara Na Ayudhya, Marilyn Cost, Yunda Huang, Fang Gai, Nicole Billitto, J D Lynam, Kara Pryke, Phillip Graebing, Nicole Hopkins, James F Rooney, David Friend, Charlene S Dezzutti

“…To validate our findings with on-going clinical trial results, we evaluated topical tenofovir gel for safety and efficacy. We also modeled systemic application of tenofovir for efficacy.Formulation assessment of tenofovir gel included osmolality, viscosity, in vitro release, and permeability testing. …”
Get full text

Acquired Fanconi Syndrome from Tenofovir Treatment in a Patient with Hepatitis B by Shirley X. Jiang, John Duncan, Hin Hin Ko

“…Finally, persistent electrolyte derangements led to urine studies, which demonstrated acquired Fanconi syndrome secondary to tenofovir. After discontinuing tenofovir disoproxil fumarate and starting tenofovir alafenamide, her symptoms resolved and her renal function recovered. …”
Get full text

Renal function in Ethiopian HIV-positive adults on antiretroviral treatment with and without tenofovir by Daniel Yilma, Alemseged Abdissa, Pernille Kæstel, Markos Tesfaye, Mette F. Olsen, Tsinuel Girma, Christian Ritz, Henrik Friis, Åse B. Andersen, Ole Kirk

Subjects: Get full text

Stress Studies of Tenofovir Disoproxil Fumarate by HPTLC in Bulk Drug and Pharmaceutical Formulation by Shweta Havele, Sunil R. Dhaneshwar

“…A stability-indicating high-performance thin-layer chromatographic (HPTLC) method for determination of tenofovir disoproxil fumarate in bulk drug and in tablet has been developed and validated. …”
Get full text